CD8A and lung carcinoma: In mice of lung cancer model, blockade of CXCR2 inhibits lung tumor growth via decreasing immune suppressive neutrophils infiltration, augmenting the activation of CD8+ T cells and improved therapeutic effect of cisplatin by modulating tumor microenvironment.